Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
6 hedge funds and large institutions have $588K invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
76% less capital invested
Capital invested by funds: $2.46M → $588K (-$1.87M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$483 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPC
Karst Peak Capital
Hong Kong
|
-$2.1M |
TLC Hedge Fund Activity: Q2 2020 in Review
6 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q2 2020, worth a combined $588K — down 76% from $2.46M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TLC positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $4.9K. The largest seller was Karst Peak Capital, exiting entirely with an estimated $2.1M sold.
- 6 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q2 2020, up from 5 in Q1 2020.
- Funds reported $588K of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q2 2020, down 76% quarter-over-quarter.
- 2 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q2 2020 and 1 closed out, a net change of +1 holder.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q2 2020 was UBS Group, an estimated $4.9K added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q2 2020 was Karst Peak Capital, an estimated $2.1M sold.
Based on aggregated 13F filings for Q2 2020.